Connection
Elizabeth Bayliss to Sulfonylurea Compounds
This is a "connection" page, showing publications Elizabeth Bayliss has written about Sulfonylurea Compounds.
|
|
Connection Strength |
|
 |
|
 |
|
0.161 |
|
|
|
-
Bennett WL, Aschmann HE, Puhan MA, Robbins CW, Bayliss EA, Wilson R, Mularski RA, Chan WV, Leff B, Sheehan O, Glover C, Maslow K, Armacost K, Mintz S, Boyd CM. A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. J Clin Epidemiol. 2019 09; 113:92-100.
Score: 0.161